Healthcare -
Biotechnology - NASDAQ - US
$ 0.5008
-4.32 %
$ 61.9 M
Market Cap
-0.83
P/E
MRSN - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity MRSN - Mersana Therapeutics, Inc.
226 M
LAST VALUE
4.73%
2 YEAR CAGR
23.56%
5 YEAR CAGR
0.00%
10 YEAR CAGR